Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
GOOG
|
John L Hennessy |
SELL
Open market or private sale
|
Indirect | 450 Reduced 4.39% |
$493,088
$1095.75 p/Share
|
Feb 05
2018 |
NILE
|
Milton C Ault Iii
Executive Chairman |
BUY
Open market or private purchase
|
Direct | 1,500 Added 16.48% |
$1,965
$1.31 p/Share
|
Feb 05
2018 |
LLY
|
Jeffrey N Simmons
SVP&Pres. Elanco Animal Health |
SELL
Open market or private sale
|
Direct | 9,625 Reduced 6.74% |
$780,780
$81.12 p/Share
|
Feb 05
2018 |
FBP
|
Crespo Luz |
SELL
Payment of exercise price or tax liability
|
Direct | 361 Reduced 0.75% |
$2,166
$6.0 p/Share
|
Feb 04
2018 |
KMPR
|
Richard Roeske
VP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,003 Reduced 1.68% |
$62,838
$62.65 p/Share
|
Feb 04
2018 |
KMPR
|
Richard Roeske
VP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,200 Added 5.09% |
-
|
Feb 04
2018 |
KMPR
|
Carl Thomas Evans Jr.
EVP, Sec. & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 3,377 Reduced 25.17% |
$211,569
$62.65 p/Share
|
Feb 04
2018 |
KMPR
|
Carl Thomas Evans Jr.
EVP, Sec. & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 11,320 Added 45.76% |
-
|
Feb 04
2018 |
KMPR
|
John Michael Boschelli
EVP & Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,824 Reduced 5.49% |
$114,274
$62.65 p/Share
|
Feb 04
2018 |
KMPR
|
John Michael Boschelli
EVP & Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct | 6,000 Added 15.31% |
-
|
Feb 04
2018 |
EVR
|
Roger C Altman
Founder and Senior Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 29,491 Reduced 13.77% |
$2,949,100
$100.0 p/Share
|
Feb 04
2018 |
EVR
|
Ostoa Augusto Arellano
CEO of EVR Mexico |
SELL
Payment of exercise price or tax liability
|
Direct | 6,900 Reduced 18.46% |
$690,000
$100.0 p/Share
|
Feb 04
2018 |
EVR
|
Edward S Hyman
Vice Chair EVR & Chairman EISI |
SELL
Payment of exercise price or tax liability
|
Direct | 656 Reduced 11.59% |
$65,600
$100.0 p/Share
|
Feb 04
2018 |
EVR
|
Jason Klurfeld
General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 470 Reduced 15.54% |
$47,000
$100.0 p/Share
|
Feb 04
2018 |
EVR
|
Paul Pensa
Contr, Prin. Acct.Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 969 Reduced 16.67% |
$96,900
$100.0 p/Share
|
Feb 04
2018 |
EVR
|
Ralph Schlosstein
Co-CEO/Co-Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 23,417 Reduced 7.38% |
$2,341,700
$100.0 p/Share
|
Feb 04
2018 |
EVR
|
Andrew Sibbald
CEO EVR Partners International |
SELL
Payment of exercise price or tax liability
|
Direct | 19,420 Reduced 15.1% |
$1,942,000
$100.0 p/Share
|
Feb 04
2018 |
EVR
|
Robert B Walsh
Principal Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,970 Reduced 6.76% |
$697,000
$100.0 p/Share
|
Feb 04
2018 |
ALLY
|
Jeffrey Jonathan Brown
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 17,430 Reduced 2.55% |
$503,553
$28.89 p/Share
|
Feb 03
2018 |
ALLY
|
David J Debrunner
VP, CAO, Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 3,097 Reduced 2.05% |
$89,472
$28.89 p/Share
|
Feb 03
2018 |
ALLY
|
Diane E. Morais
President, Ally Bank |
SELL
Payment of exercise price or tax liability
|
Direct | 6,882 Reduced 2.85% |
$198,821
$28.89 p/Share
|
Feb 03
2018 |
FITB
|
Lars C Anderson
EVP |
SELL
Payment of exercise price or tax liability
|
Direct | 2,655 Reduced 1.13% |
$87,960
$33.13 p/Share
|
Feb 03
2018 |
FITB
|
Greg D Carmichael
Executive Chair |
SELL
Payment of exercise price or tax liability
|
Direct | 8,181 Reduced 1.38% |
$271,037
$33.13 p/Share
|
Feb 03
2018 |
FITB
|
Frank R. Forrest
EVP |
SELL
Payment of exercise price or tax liability
|
Direct | 2,202 Reduced 1.86% |
$72,952
$33.13 p/Share
|
Feb 03
2018 |
FITB
|
Mark D Hazel
EVP and Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 437 Reduced 0.63% |
$14,478
$33.13 p/Share
|
Feb 03
2018 |
FITB
|
Aravind Immaneni
EVP and CTO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,064 Reduced 4.07% |
$35,250
$33.13 p/Share
|
Feb 03
2018 |
FITB
|
James C. Leonard
EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,130 Reduced 1.01% |
$37,437
$33.13 p/Share
|
Feb 03
2018 |
FITB
|
Philip Mc Hugh
EVP |
SELL
Payment of exercise price or tax liability
|
Direct | 936 Reduced 0.55% |
$31,010
$33.13 p/Share
|
Feb 03
2018 |
FITB
|
Jelena Mc Williams
EVP and CLO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,064 Reduced 11.76% |
$35,250
$33.13 p/Share
|
Feb 03
2018 |
FITB
|
Timothy Spence
Chair, CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct | 2,726 Reduced 1.61% |
$90,312
$33.13 p/Share
|
Feb 03
2018 |
FITB
|
Teresa J. Tanner
EVP and CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,110 Reduced 2.95% |
$69,904
$33.13 p/Share
|
Feb 03
2018 |
FITB
|
Tayfun Tuzun
EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,216 Reduced 1.66% |
$73,416
$33.13 p/Share
|
Feb 03
2018 |
GNW
|
Lori M Evangel
EVP & Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 576 Reduced 1.27% |
$1,757
$3.05 p/Share
|
Feb 03
2018 |
GNW
|
Lori M Evangel
EVP & Chief Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 1,625 Added 3.46% |
-
|
Feb 03
2018 |
PRTK
|
Michael Bigham
Exec. Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct | 23,255 Added 1.68% |
$99,996
$4.3 p/Share
|
Feb 02
2018 |
TMUS
|
Elizabeth A. Mc Auliffe
EVP, Human Resources |
SELL
Open market or private sale
|
Direct | 4,090 Reduced 5.66% |
$249,654
$61.04 p/Share
|
Feb 02
2018 |
EA
|
Jacob J. Schatz
EVP, Global Affairs and CLO |
SELL
Bona fide gift
|
Direct | 400 Reduced 2.23% |
-
|
Feb 02
2018 |
ALIM
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 0 Added 0.0% |
-
|
Feb 02
2018 |
ALIM
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 8,000 Added 0.12% |
$9,280
$1.16 p/Share
|
Feb 02
2018 |
RM
|
Basswood Capital Management, L.L.C. |
BUY
Grant, award, or other acquisition
|
Indirect | 799 Added 50.0% |
-
|
Feb 02
2018 |
KALA
|
Orbimed Advisors LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 37,840 Added 1.09% |
$557,383
$14.73 p/Share
|
Feb 02
2018 |
PCF
|
Bulldog Investors, LLP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 100 Added 0.01% |
$900
$9.0 p/Share
|
Feb 02
2018 |
BH
|
Biglari, Sardar
Director |
BUY
Open market or private purchase
|
Indirect | 1,218 Added 0.17% |
$496,530
$407.66 p/Share
|
Feb 02
2018 |
LAB
|
Levin Capital Strategies, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 17,100 Added 0.16% |
$103,455
$6.05 p/Share
|
Feb 02
2018 |
LNC
|
Ellen Cooper
President & CEO |
SELL
Open market or private sale
|
Direct | 7,300 Reduced 9.24% |
$620,573
$85.01 p/Share
|
Feb 02
2018 |
LNC
|
Ellen Cooper
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,300 Added 1.62% |
$29,510
$22.7 p/Share
|
Feb 02
2018 |
LNC
|
Dennis R Glass |
SELL
Open market or private sale
|
Direct | 102,367 Reduced 13.73% |
$8,680,722
$84.8 p/Share
|
Feb 02
2018 |
LNC
|
Lisa Buckingham
EVP, Ch Pple Place Brand Off |
SELL
Open market or private sale
|
Direct | 9,462 Reduced 14.77% |
$799,634
$84.51 p/Share
|
Feb 02
2018 |
LNC
|
Lisa Buckingham
EVP, Ch Pple Place Brand Off |
BUY
Exercise of conversion of derivative security
|
Direct | 9,462 Added 12.87% |
$279,507
$29.54 p/Share
|
Feb 02
2018 |
LNC
|
Randal J Freitag
EVP & CFO |
SELL
Open market or private sale
|
Direct | 31,657 Reduced 19.61% |
$2,669,318
$84.32 p/Share
|
Feb 02
2018 |